Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × Rectal Neoplasms × Clear all

Phase

Phase 2 23 Phase NA 21 Phase 1 9 Phase 3 8 Phase 1/2 6 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Unknown 10 Completed 4 Recruiting 3 Not yet recruiting 3 Terminated 2 Withdrawn 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Recurrence 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Colonic Neoplasms 3 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia 2 Hyperthermia 2 Fallopian Tube Neoplasms 2 Delirium 2 Cholangiocarcinoma 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1

Interventions

Radiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02945566 2025-03-27

STAR-TREC

University of Birmingham

Phase 2/3 Active not recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡